Facheng Bai

410 total citations
14 papers, 268 citations indexed

About

Facheng Bai is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Facheng Bai has authored 14 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Facheng Bai's work include Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (7 papers) and Cancer Mechanisms and Therapy (2 papers). Facheng Bai is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (7 papers) and Cancer Mechanisms and Therapy (2 papers). Facheng Bai collaborates with scholars based in China, United States and Singapore. Facheng Bai's co-authors include Xing Lin, Quanfang Huang, Jinbin Wei, Zhongpeng Lu, Lang Zhuo, Xiaolin Zhang, Lijun Pang, Bo Zhang, Ling‐Ping Lai and Chunyuan Lu and has published in prestigious journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Facheng Bai

14 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Facheng Bai China 10 138 101 93 41 29 14 268
Mao‐xu Ge China 11 157 1.1× 123 1.2× 133 1.4× 58 1.4× 32 1.1× 15 357
José C. Fernández-Checa Spain 7 92 0.7× 58 0.6× 120 1.3× 32 0.8× 18 0.6× 10 266
Baoyu Liang China 7 90 0.7× 62 0.6× 118 1.3× 32 0.8× 17 0.6× 10 276
Xuguang Zhai China 12 203 1.5× 139 1.4× 162 1.7× 37 0.9× 30 1.0× 25 405
Chaoliang Ge China 8 171 1.2× 122 1.2× 90 1.0× 49 1.2× 27 0.9× 12 323
Hany M. Fayed Egypt 13 107 0.8× 99 1.0× 82 0.9× 64 1.6× 14 0.5× 24 307
Rongtao Lai China 11 169 1.2× 84 0.8× 78 0.8× 61 1.5× 21 0.7× 22 324
Liuying Chen China 10 140 1.0× 87 0.9× 127 1.4× 23 0.6× 21 0.7× 17 324
Nashwa Abu‐Elsaad Egypt 12 93 0.7× 75 0.7× 114 1.2× 39 1.0× 11 0.4× 22 349
Weiguang Ren China 10 153 1.1× 92 0.9× 124 1.3× 31 0.8× 20 0.7× 24 333

Countries citing papers authored by Facheng Bai

Since Specialization
Citations

This map shows the geographic impact of Facheng Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Facheng Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Facheng Bai more than expected).

Fields of papers citing papers by Facheng Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Facheng Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Facheng Bai. The network helps show where Facheng Bai may publish in the future.

Co-authorship network of co-authors of Facheng Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Facheng Bai. A scholar is included among the top collaborators of Facheng Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Facheng Bai. Facheng Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lai, Zongqiang, et al.. (2024). Tumor-targeted gypenoside nanodrug delivery system with double protective layers. Journal of Cancer Research and Therapeutics. 20(2). 684–694. 2 indexed citations
2.
Lai, Zongqiang, et al.. (2024). Visual analysis of hotspots and trends in long COVID research based on bibliometric. Heliyon. 10(2). e24053–e24053. 3 indexed citations
3.
Bai, Facheng, Zhenguang Huang, Yue Qiu, et al.. (2023). Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022. Frontiers in Pharmacology. 14. 1164425–1164425. 12 indexed citations
4.
5.
Fang, Bin, Yan Li, Facheng Bai, et al.. (2021). Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways. International Immunopharmacology. 92. 107208–107208. 16 indexed citations
6.
7.
Liu, Lin, Hongyuan Wang, Facheng Bai, et al.. (2019). HBOA ameliorates CCl4-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways. Biomedicine & Pharmacotherapy. 115. 108901–108901. 21 indexed citations
8.
Zhang, Xiaolin, et al.. (2018). Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy. Cellular Physiology and Biochemistry. 51(2). 897–908. 23 indexed citations
9.
Huang, Quanfang, Xiaolin Zhang, Facheng Bai, et al.. (2018). Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. International Immunopharmacology. 66. 41–51. 23 indexed citations
10.
Wang, Dandan, Qian Qiao, Lijun Pang, et al.. (2018). Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism. International Immunopharmacology. 65. 256–267. 40 indexed citations
11.
Lin, Xing, Jinbin Wei, Facheng Bai, et al.. (2018). Inhibition of RKIP aggravates thioacetamide‑induced acute liver failure in mice. Experimental and Therapeutic Medicine. 9 indexed citations
12.
Bai, Facheng, Quanfang Huang, Jinbin Wei, et al.. (2017). Gypsophila elegans isoorientin-2″-O-α-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation. International Immunopharmacology. 54. 60–67. 22 indexed citations
13.
Bai, Facheng, Quanfang Huang, Chunyuan Lu, et al.. (2017). Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy. Cellular Physiology and Biochemistry. 44(2). 436–446. 42 indexed citations
14.
Wei, Jinbin, Quanfang Huang, Facheng Bai, et al.. (2016). Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells. Chemico-Biological Interactions. 261. 118–126. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mao‐xu Ge Breakdown of academic impact, for papers by José C. Fernández-Checa Breakdown of academic impact, for papers by Baoyu Liang Breakdown of academic impact, for papers by Xuguang Zhai Breakdown of academic impact, for papers by Chaoliang Ge Breakdown of academic impact, for papers by Hany M. Fayed Breakdown of academic impact, for papers by Rongtao Lai Breakdown of academic impact, for papers by Liuying Chen Breakdown of academic impact, for papers by Nashwa Abu‐Elsaad Breakdown of academic impact, for papers by Weiguang Ren
Rankless by CCL
2026